Clinical Trials Logo

Clinical Trial Summary

Retinal vasculitis is a sight-threatening inflammation that involves the blood vessels of the retina, the tissue that lines the inside of the eye. This inflammation may occur on its own or as a result of an infectious, cancerous, or inflammatory disorder. Optical coherence tomography (OCT) is an imaging technology that can perform non-contact cross-sectional imaging of retinal and choroidal tissue structure in real time. It is similar to ultrasound imaging, except that OCT measures the intensity of reflected light rather than sound waves. The purpose of this study is to see if non-invasive OCT technology can diagnose retinal vasculitis as well as the more invasive fluorescein angiography, which requires an injection of dye into the vein of an arm of a patient. The study will also compare the mapping of blood vessels (angiography) and loss of blood flow (ischemia) by fluorescein angiography and OCT.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01998464
Study type Observational
Source Oregon Health and Science University
Contact
Status Completed
Phase
Start date January 2014
Completion date August 23, 2018

See also
  Status Clinical Trial Phase
Completed NCT00167583 - Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB) Phase 3
Completed NCT03264391 - Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography
Completed NCT00050492 - Biological Markers in Retinal Vasculitis N/A
Not yet recruiting NCT06343961 - Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy N/A